Bullish Trend In NanoViricides (NNVC) Shares Following Promising Clinical Findings
Following the release of encouraging clinical trial data, shares of NanoViricides, Inc. (NYSE: NNVC) are demonstrating a bullish trend on US stock charts. As of the latest current-market check, NNVC stock increased by 7.92% to $3.27. Breakthrough Findings On NV-387 NanoViricides (NNVC) reported that its leading clinical-stage broad-spectrum antiviral drug candidate, NV-387, exhibits an ideal […]
Bullish Trend In NanoViricides (NNVC) Shares Following Promising Clinical Findings Read More »
